Tag: Sanofi

Sanofi Aventis Ukraine will resort to International Investment Arbitration

Sanofi Aventis Ukraine LLC, part of Sanofi global pharmaceutical company, seeks to file a claim against Ukraine to the International Investment Arbitration.

Sanofi and Axxam started collaboration focused on CNS diseases

Axxam, an innovative Partner Research Organization (iPRO), announced the start of a research collaboration with Sanofi

Sanofi launches a multiple sclerosis drug in the Russian market

Sanofi announced the launch of Lemtrada, a drug for the treatment of active relapsing-remitting multiple sclerosis, in the Russian market

Ablynx and Sanofi joined for a research collaboration

Ablynx, a biopharmaceutical company, today announced that it has entered into a research collaboration and global exclusive licensing agreement with Sanofi

Emergent Biosolutions bought ACAM2000 business of Sanofi

Emergent BioSolutions Inc., a global life sciences company, announced today that it has entered into an agreement to acquire the ACAM2000® (Smallpox vaccine) business of Sanofi in an all-cash transact...

Sanofi will buy Protein Sciences biotechnology company

Sanofi announced today it will acquire Protein Sciences, a privately held vaccines biotechnology company

Sanofi and Regeneron received European approval for Kevzara

Sanofi and Regeneron Pharmaceuticals, Inc. announced today that the European Commission (EC) has granted marketing authorization for Kevzara

Sanofi plans to invest EUR600 million in the field of biologics

French drugmaker and healthcare group Sanofi announced plans to invest 600 million euros annually over the next two to three years in the field of biologics

Sanofi start shipments of insulin from Russian plant to EU

Sanofi announced that it starts to export the insulins produced at Sanofi-Aventis Vostok plant in the Oryol region to the European Union

Sanofi and Russian Federal Research Center signed a memorandum of partnership

Sanofi and Federal Almazov North-West Medical Research Center of the Russian Ministry of Health signed a memorandum aimed at strategic partnership in the area of health care

Sanofi will destroy its unused API plant in France

Sanofi, a French pharmaceutical company, will demolish a plant it spent about $118 million to build and never even used.

Sanofi and Exscientia announced €250 million R&D collaboration

Exscientia, an innovative company at the forefront of Artificial Intelligence (AI)-driven drug discovery, is pleased to announce that it has agreed a strategic research collaboration, and licence opti...

Kazakhstan will provide a six-component vaccine by Sanofi Pasteur for children

As part of guaranteed free medical care, Kazakhstan will provide children with Hexaxim®, a high-quality European vaccine produced by Sanofi Pasteur, a division of Sanofi, a French pharmaceutical compa...

Sanofi and Russian Health of the Nation League join efforts

Sanofi announced the signing of strategic partnership agreement with Health of the Nation League, an All-Russian public organization, to fight non-infectious diseases. The document was signed by acade...

Sanofi Pasteur will pay $19.8 million to U.S. government

Sanofi Pasteur agreed to the payment to resolve claims it overcharged the US Department of Veterans Affairs (VA) for drugs under two contracts between 2002 and 2011. The US Department of Justice sa...

Sanofi Pasteur localized the manufacturing of vaccines at NANOLEK site

Sanofi Pasteur, a division of Sanofi Group, announced that the company’s pentavalent combination vaccine intended for the Russian market is manufactured on the production site of NANOLEK, an innovativ...